Not Tagged
immunicom,gilead sciences
['$gild', '$immu']
if $immu is still around as a public company, after the #asco22 data presentation, what valuation should it be if it is still on the public listing.. maybe that gap vs the 22b deal price would be the amount $gild has to write down eventually - ha!